Takeda Announces FY2020 Q1 Results; Confirms Management Guidance & Raises Reported Operating Profit And Reported Net Profit for the Full YearBusiness Wire • 07/31/20
Takeda's Entyvio and Janssen's Stelara Share of Inflammatory Bowel Disease Biologic-Naive Patients Continues to Increase as This Patient Group Expands Their Involvement in the Decision-Making ProcessPRNewsWire • 07/30/20
Takeda Announces U.S. FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with Higher-Risk Myelodysplastic Syndromes (HR-MDS)Business Wire • 07/30/20
Takeda estimates £162.50 million hit to operating loss as Novartis withdraws from European approval for XiidraInvezz • 06/29/20
Japan's Takeda expects $200 million operating loss related to Novartis' Xiidra withdrawalReuters • 06/29/20
Exclusive: Blackstone, Taisho Pharma among final bidders for Takeda's Japan OTC unit - sourcesReuters • 06/19/20
Takeda Pharmaceutical Company Limited (TKPHF) on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/13/20
CSL Behring and Takeda Pharmaceutical Are Leading a Coalition to Develop a COVID-19 Hyperimmune TherapyThe Motley Fool • 04/08/20
Big Pharma's Fight Against the Coronavirus Pandemic: Good News and Bad NewsThe Motley Fool • 03/19/20